Tandem Meetings 2026
At this year’s Tandem Meetings, taking place 4–7 February 2026, in Salt Lake City, Utah, we are proud to be sharing new data and engaging with the scientific community to drive progress in the care of people living with blood cancers.
You can see the conference program here:
Our scientific areas of focus at the 2026 Tandem Meetings
We are pleased to share new research presented at this year's Tandem Meetings.
Our information may reference an investigational agent or an investigational use of an FDA approved product. The safety and efficacy for investigational uses or agents have not been established or approved by the FDA.
Abstract ID
Title / Presenting Author
Room / Date
74
A Phase 1 Study of KITE-753 or KITE-363 in Patients With Relapsed/Refractory B-Cell Lymphoma: Initial Safety and Preliminary Efficacy of KITE-753 and Updated Results of KITE-363
Presenting Author: Saurabh Dahiya
Room: Ballroom AB (Salt Palace Convention Center)
Date: Saturday, Feb 7, 10:45 AM - 11:00 AM MST
Click here to view full abstractAbstract ID
Title / Presenting Author
Room / Date
237
Inpatient Versus Outpatient Administration of CAR T-cell Therapy in relapsed/refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL): Real-World 30- and 60-Day Costs and Resource Utilization
Presenting Author: Samuel Hong
Room: Poster Hall AB (Salt Palace Convention Center)
Date: Thurs, Feb 5, 2026, 6:30 PM MST
Click here to view full abstract513
Estimating the survival impact of not receiving CAR T-cell (CAR T) therapy when eligible in patients with Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL) in the United States (US)
Presenting Author: Frederick Locke
Room: Poster Hall AB (Salt Palace Convention Center)
Date: Thurs, Feb 5, 2026, 6:30 PM MST
Click here to view full abstract269
Systematic Literature Review of Characteristics Associated with Safety and Healthcare Resource Utilization Outcomes in Various Settings of Care for Chimeric Antigen Receptor T-Cell Therapy
Presenting Author: Samuel Hong
Room: Poster Hall AB (Salt Palace Convention Center)
Date: Thurs, Feb 5, 2026, 6:30 PM MST
Click here to view full abstract398
Collaboration
Visualizing Geographic Variation and Systemic Inequities of Disease Burden and CAR T-Cell Therapy Access in Multiple Myeloma in the US
Presenting Author: Brandon Blue
Room: Poster Hall AB (Salt Palace Convention Center)
Date: Thurs, Feb 5, 2026, 6:30 PM MST
Click here to view full abstract279
Collaboration
Anito-Cel's D-Domain Binder Has a Fast Off-Rate and Contributes to Its Differentiated Pharmacology Profile in Multiple Myeloma
Presenting Author: Kevin Hart
Room: Poster Hall AB (Salt Palace Convention Center)
Date: Thurs, Feb 5, 2026, 6:30 PM MST
Click here to view full abstract232
Collaboration
Impact of treatment and sequencing with CAR T-cell therapies and bispecific antibodies on long-term survival in 4L+ RRMM in the US: a simulation model
Presenting Author: Jodi Lipof
Room: Poster Hall AB (Salt Palace Convention Center)
Date: Thurs, Feb 5, 2026, 6:30 PM MST
Click here to view full abstract